Assignee
SAMSUNG BIOEPIS CO LTD
KR·12 granted patents·14 pending applications·91 citations·filing 2015–2025
Top patents by PatentIndex Score
26 records- 0189USD867583SInjector for medicineSAMSUNG BIOEPIS CO LTD·Filed 2017·Granted Nov 19, 2019·38 cites·1 claims
- 0282US10336828B2Fusion polynucleotide containing murine CMV promoter and method of preparing a polypeptide of interest using the sameSAMSUNG BIOEPIS CO LTD·Filed 2015·Granted Jul 2, 2019·3 cites·20 claims
- 0373USD904879SBox for packagingSAMSUNG BIOEPIS CO LTD·Filed 2019·Granted Dec 15, 2020·15 cites·1 claims
- 0473US2026042818A1Anti-tnf-alpha polypeptide composition and use thereofSAMSUNG BIOEPIS CO LTD·Filed 2025·Application pending·0 cites
- 0572US10202456B2Method for producing polypeptides using PDK-inactivated cellsSAMSUNG BIOEPIS CO LTD·Filed 2015·Granted Feb 12, 2019·1 cites·19 claims
- 0666USD904878SBox for packagingSAMSUNG BIOEPIS CO LTD·Filed 2019·Granted Dec 15, 2020·11 cites·1 claims
- 0763US2021347878A1Pharmaceutical composition comprising antibody, device comprising same, and use thereofSAMSUNG BIOEPIS CO LTD·Filed 2021·Application pending·0 cites
- 0863US2021347877A1Pharmaceutical composition comprising antibody, device comprising same, and use thereofSAMSUNG BIOEPIS CO LTD·Filed 2021·Application pending·0 cites
- 0959USD833603SInjector bodySAMSUNG BIOEPIS CO LTD·Filed 2017·Granted Nov 13, 2018·8 cites·1 claims
- 1057US2022081478A1Pharmaceutical composition comprising antibody, device comprising same, and use thereofSAMSUNG BIOEPIS CO LTD·Filed 2020·Application pending·0 cites
- 1154US2023115267A1Pharmaceutical liquid composition having increased stabilitySAMSUNG BIOEPIS CO LTD·Filed 2021·Application pending·0 cites
- 1253US2022008536A1Stable liquid composition comprising proteinSAMSUNG BIOEPIS CO LTD·Filed 2019·Application pending·0 cites
- 1353US2020062822A1Anti-tnf-alpha polypeptide composition and use thereofSAMSUNG BIOEPIS CO LTD·Filed 2019·Application pending·0 cites
- 1452US2023192893A1Human genome-derived polynucleotide and method for producing polypeptide of interest using sameSAMSUNG BIOEPIS CO LTD·Filed 2020·Application pending·0 cites
- 1551US12594322B2Liquid composition comprising proteinSAMSUNG BIOEPIS CO LTD·Filed 2019·Granted Apr 7, 2026·0 cites·12 claims
- 1649USD855451SBox for packagingSAMSUNG BIOEPIS CO LTD·Filed 2018·Granted Aug 6, 2019·6 cites·1 claims
- 1743US2020390693A1Liquid composition comprising vegf antagonistSAMSUNG BIOEPIS CO LTD·Filed 2018·Application pending·0 cites
- 1843US2023203554A1Process for reducing unwanted culture byproducts in cell culture mediumSAMSUNG BIOEPIS CO LTD·Filed 2017·Application pending·0 cites
- 1943US2023054413A1Stable anti-pd1 antibody pharmaceutical formulationsSAMSUNG BIOEPIS CO LTD·Filed 2020·Application pending·0 cites
- 2042USD834183SInjector bodySAMSUNG BIOEPIS CO LTD·Filed 2017·Granted Nov 20, 2018·3 cites·1 claims
- 2142US2023119778A1Stable anti-pd-1 antibody pharmaceutical formulationsSAMSUNG BIOEPIS CO LTD·Filed 2021·Application pending·0 cites
- 2242US2018079796A1Anti-tnf-alpha polypeptide composition and use thereofSAMSUNG BIOEPIS CO LTD·Filed 2016·Application pending·0 cites
- 2341USD855176SInjector for medicineSAMSUNG BIOEPIS CO LTD·Filed 2017·Granted Jul 30, 2019·3 cites·1 claims
- 2441US2019330319A1Stable aqueous anti-c5 antibody compositionSAMSUNG BIOEPIS CO LTD·Filed 2017·Application pending·0 cites
- 2537USD864379SInjector bodySAMSUNG BIOEPIS CO LTD·Filed 2017·Granted Oct 22, 2019·2 cites·1 claims
- 2628USD979053SSyringe capSAMSUNG BIOEPIS CO LTD·Filed 2019·Granted Feb 21, 2023·1 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when SAMSUNG BIOEPIS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →